Tag: COVID-19

FDA, Industry, News, Pricing, Regulations, Vaccines

US backs proposal to waive IP protection for COVID-19 vaccines

May 7, 2021


The Biden-Harris Administration is backing a proposal from the World Trade Organization (WTO), supported by South Africa and India, that would temporarily remove IP protections on COVID-19 vaccines. The move itself is surprising, given that historically the US has been […]

Cell and Gene Therapy, Industry

Resource Links Gene Variants with Immune System Regulation and Immune-Mediated Diseases

April 30, 2021

Via: Genetic Engineering and Biotechnology News

University of Tokyo researchers and colleagues at the RIKEN Research Institute have compiled a first-of-its-kind genetic database for autoimmune and autoinflammatory diseases. It’s hoped that the resource will offer up new insights into how immune disorders develop, and potentially aid […]

Industry, Vaccines

The invisible work in the vaccine roll-out

April 28, 2021

Via: EPM Magazine

We are seeing incredible progress in the roll-out of Covid-19 vaccines. We are on track for all adults in the UK to have been offered the vaccine by July. Researchers and healthcare workers are rightfully being celebrated for all their […]

Industry, Vaccines

Why delivering Covid-19 vaccines is the logistics industry’s biggest challenge

April 14, 2021

Via: EPM Magazine

The sheer speed of developing and gaining regulatory approval for effective vaccines against Covid-19 has been unprecedented. Transporting them rapidly and safely from manufacturing sites to vaccination centres and doctors’ surgeries across the world is possibly the biggest challenge the […]

Biotech, FDA, Industry, Regulations

Airway Therapeutics Announces FDA Acceptance of IND for AT-100’s Second Indication in Severe COVID-19 Patients

April 12, 2021

Via: BioSpace

Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, today announced the U.S. Food and Drug Administration (FDA) has accepted its Investigational […]

Biotech, Industry, Manufacturing, News, Research and Development, Vaccines

Emergent BioSolutions On Track with Respect to COVID-19 Contractual Commitments

April 5, 2021

Via: BioSpace

Emergent BioSolutions Inc. (NYSE:EBS) today announced that the Company continues to be on track with its manufacturing agreements related to COVID-19 vaccines and confirmed that there are no changes to its financial guidance for 2021. In addition, the Company received […]

Industry, News, Vaccines

COVID-19 Vaccine Market: Nucleic acid vaccines segment to dominate global market

April 2, 2021

Via: BioSpace

COVID-19 is a pneumonic disease that is caused by SARS-Cov2 virus. Previous ancestors of COVID-19 virus are SARS-CoV and MERS Virus. Loss of few base pairs has led to the mutation in the genetic material of SARS-CoV2. High multiplication rate […]

Clinical Trials, Industry, Research and Development, Vaccines

Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results in Non-Human Primates Vaccinated with TNX-1800 and Challenged with Live SARS-CoV-2

March 17, 2021

Via: BioSpace

Tonix Pharmaceuticals, Inc.. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced preliminary results following vaccination of non-human primates with TNX-1800 (modified horsepox virus, live vaccine), a live attenuated COVID-19 vaccine candidate engineered to express the SARS-CoV-2 […]

Industry, News, Vaccines

European Union countries clash over unequal vaccine distribution

March 15, 2021


Six members of the European Union have raised concerns over how the bloc is distributing Covid-19 vaccines, after AstraZeneca cut its delivery targets once again. Austria, Latvia, the Czech Republic, Bulgaria, Croatia and Slovenia wrote to the European Commission on […]

Industry, News, Vaccines

Britain denies ‘completely false’ EU claims as a new vaccine dispute boils over

March 10, 2021


The European Union and the United Kingdom have clashed over the export of coronavirus vaccines, with Britain fiercely denying it has blocked any shipments to other nations. The latest battle emerged after European Council President Charles Michel accused the U.K. […]


Eurofins Launches Quantitative Antibody Test to Measure Immune Response to COVID-19 and Vaccines

February 11, 2021

Via: BioSpace

Eurofins launches a new CE marked serological assay for the identification and quantification of antibodies to SARS-CoV-2. This ELISA kit can support vaccination campaigns by confirming the success of a vaccination and monitoring the antibody levels over time. Vaccination against […]

FDA, Regulations

FDA Authorizes Lilly COVID-19 Antibody Combination for Emergency Use

February 10, 2021

Via: Genetic Engineering and Biotechnology News

The FDA last night granted Emergency Use Authorization (EUA) for a 700 mg dose of bamlanivimab (LY-CoV555) in combination with a 1400 mg dose of a second Lilly antibody candidate, etesevimab (LY-CoV016), for the treatment of mild to moderate COVID-19 […]